Related Experiment Videos
Sentinel lymphadenectomy: a safe answer to less axillary surgery?
1Department of Surgery, University of South Florida, College of Medicine, Tampa, USA.
Summary
Sentinel lymph node biopsy (SLNB) accurately predicts breast cancer nodal status. This technique shows high sensitivity and accuracy, potentially reducing the need for extensive axillary surgery and chemotherapy.
Area of Science:
- Oncology
- Surgical Pathology
- Nuclear Medicine
Background:
- Breast cancer management relies on accurate staging of nodal involvement.
- Sentinel lymph node biopsy (SLNB) is an evolving technique to assess axillary lymph node status.
- Traditional axillary lymph node dissection carries significant morbidity.
Purpose of the Study:
- To prospectively evaluate the safety and efficacy of SLNB in breast cancer patients.
- To review global literature on SLNB for breast cancer staging.
- To establish SLNB as a standard of care for breast cancer treatment.
Main Methods:
- Prospective study of 167 breast cancer patients undergoing SLNB.
- Intra-operative lymphatic mapping using vital blue dye and technetium-labeled sulfur colloid.
- Detailed pathological examination of sentinel lymph nodes (SLNs) including immunohistochemistry.
Main Results:
- SLNB identified metastasis in 31.1% of patients.
- The false negative rate was 0.88% in this study.
- Literature review of 731 patients showed 95% sensitivity and 98% diagnostic accuracy for SLNB.
Conclusions:
- SLNB is a highly sensitive and accurate method for predicting axillary nodal status in breast cancer.
- The technique is reproducible and easily learned, supporting its adoption into standard care.
- Future advancements like PCR may further refine nodal assessment, potentially reducing adjuvant chemotherapy use.